Abstract
No Abstract
References
Radovic M, Balint B, Milenkovic Lj, Tiska–Rudman Lj, Taseski J. Therapeutic leukapheresis. Transf Sci 1991; 12(3): 193–6.
Balint B, Ostojic G, Pavlovic M, Hrvacevic R, Pavlovic M, Tukic Lj, et al. Cytapheresis in the treatment of cell-affected blood dis-orders and abnormalities. Transf Apher Sci 2006; 35(1): 25–31.
Koren-Michowitz M, Lavi N, Ellis MH, Vannucchi AM, Mesa R, Harrison CN. Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician sur-vey. Ann Hematol 2017; 96(1): 87–92.
Prakash S, Hans R, Sharma RR, Malhotra P, Marwaha N. Thera-peutic thrombocytapheresis for symptomatic thrombocytosis in hemato-oncology patients. Ther Apher Dial 2018; 22(1): 93–5.
Balint B, Vucetic V, Trajkovic–Lakic Z, Petakov M, Bugarski M, Brajuskovic G, et al. Quantitative, functional, morphological and ultrastructural recovery of platelets as predictor for cryo-preservation efficacy. Haematologia 2002; 32(4): 363–76.
Balint B, Paunovic D, Vucetic D, Vojvodic D, Petakov M, Trkuljic M, et al. Controlled–rate vs. uncontrolled–rate freezing as predictors for platelet cryopreservation efficacy. Transfusion 2006; 46(2): 230–5.
Almeida-Dias R, Garrote M, Cid J, Mustieles MJ, Alba C, Lozano M. Therapeutic thrombocytapheresis for extreme thrombocy-tosis after chemotherapy in essential thrombocytosis. J Clin Apher. 2019; doi: 10.1002/jca.21683. (In Press)